Snowball logo
logo
NRSN

Neurosense Therapeutics Ltd

NRSN NASDAQ
$0.85-$0.026  (2.97%)

Frequently asked questions

What sector does Neurosense Therapeutics Ltd (NRSN) operate in?

Neurosense Therapeutics Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Neurosense Therapeutics Ltd (NRSN) current stock price?

As of the latest data, Neurosense Therapeutics Ltd stock price is $0.85, with a previous close of $0.88. Neurosense Therapeutics Ltd lost -$0.03 in the last trading session, representing a -2.97% loss.

What is Neurosense Therapeutics Ltd (NRSN) current market capitalization?

Neurosense Therapeutics Ltd market cap is approximately 25.12 million.

What is Neurosense Therapeutics Ltd (NRSN) Earnings Per Share (EPS)?

The trailing EPS is -$0.36, and the forward EPS is -$0.18.

Does Neurosense Therapeutics Ltd (NRSN) pay dividends?

No. Neurosense Therapeutics Ltd does not pay a dividend.

When is Neurosense Therapeutics Ltd (NRSN) next earnings report?

Neurosense Therapeutics Ltd is expected to release its next earnings report on December 31, 2025.

What is Neurosense Therapeutics Ltd (NRSN) beta (volatility) score?

Neurosense Therapeutics Ltd has a beta of 1.565, suggesting it is more volatile than the market.